Literature DB >> 2578950

Effect of sodium vanadate on deoxyribonucleic acid and protein syntheses in cultured rat calvariae.

E Canalis.   

Abstract

Sodium vanadate, an agent known to have multiple cellular actions, was studied for its effects on aspects of bone formation in cultures of 21-day-old fetal rat calvariae. Vanadate (0.1-10 microM) stimulated the incorporation of [3H] thymidine into acid-insoluble residues (DNA); the effect appeared after 3 h and was sustained for 96 h. Vanadate increased the bone DNA content and mitotic index. Treatment with vanadate at 10 microM for 24 h or at 0.3-1 microM for 96 h increased the incorporation of [3H]proline into collagenase-digestible protein (CDP), but the effect was not specific for collagen; vanadate also increased the labeling of noncollagen protein (NCP). Vanadate increased the incorporation of [3H]proline into type I collagen without affecting other collagen types. Vanadate (100 microM) caused a marked and irreversible inhibitory effect on the labeling of DNA, CDP, and NCP. Treatment with vanadate at multiple doses for 3-96 h did not stimulate alkaline phosphatase activity, but this enzyme was inhibited in bones exposed to 1 mM vanadate for 24 h or 10 microM vanadate for 96 h. The stimulatory effect on DNA labeling was primarily observed in the periosteum, while that on CDP labeling was seen only in the periosteum-free bone. These studies indicate that sodium vanadate stimulates bone DNA, collagen, and NCP syntheses in vitro, although high doses of vanadate have an irreversible inhibitory effect.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578950     DOI: 10.1210/endo-116-3-855

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

1.  Proliferative and mineralogenic effects of insulin, IGF-1, and vanadate in fish osteoblast-like cells.

Authors:  Daniel M Tiago; M Leonor Cancela; Vincent Laizé
Journal:  J Bone Miner Metab       Date:  2010-12-23       Impact factor: 2.626

2.  The relationship between insulin and vanadium metabolism in insulin target tissues.

Authors:  F G Hamel; W C Duckworth
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 3.  Unique and selective mitogenic effects of vanadate on SV40-transformed cells.

Authors:  H Wang; R E Scott
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 4.  In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus.

Authors:  A B Goldfine; D C Simonson; F Folli; M E Patti; C R Kahn
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

5.  Tyrosine phosphorylation and morphological transformation induced by four vanadium compounds on MC3T3E1 cells.

Authors:  V C Sálice; A M Cortizo; C L Gómez Dumm; S B Etcheverry
Journal:  Mol Cell Biochem       Date:  1999-08       Impact factor: 3.396

6.  Stimulatory effect of genistein and daidzein on protein synthesis in osteoblastic MC3T3-E1 cells: activation of aminoacyl-tRNA synthetase.

Authors:  M Yamaguchi; E Sugimoto
Journal:  Mol Cell Biochem       Date:  2000-11       Impact factor: 3.396

7.  Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines.

Authors:  Y Engelbrecht; H de Wet; K Horsch; C R Langeveldt; F S Hough; P A Hulley
Journal:  Endocrinology       Date:  2003-02       Impact factor: 4.736

8.  Synthesis of a new vanadyl(IV) complex with trehalose (TreVO): insulin-mimetic activities in osteoblast-like cells in culture.

Authors:  Daniel A Barrio; Patricia A M Williams; Ana M Cortizo; Susana B Etcheverry
Journal:  J Biol Inorg Chem       Date:  2003-02-13       Impact factor: 3.358

9.  Vanadium derivatives act as growth factor--mimetic compounds upon differentiation and proliferation of osteoblast-like UMR106 cells.

Authors:  A M Cortizo; S B Etcheverry
Journal:  Mol Cell Biochem       Date:  1995-04-26       Impact factor: 3.396

10.  Activation of mesangial cells by the phosphatase inhibitor vanadate. Potential implications for diabetic nephropathy.

Authors:  U O Wenzel; B Fouqueray; P Biswas; G Grandaliano; G G Choudhury; H E Abboud
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.